CUAMC
BDTX icon

China Universal Asset Management Company’s Black Diamond Therapeutics BDTX Stock Holding History

China Universal Asset Management Company’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.9K Sell
9,120
-991
-10% -$2.42K ﹤0.01% 499
2026
Q1 		$21.5K Buy
10,111
+827
+9% +$1.97K ﹤0.01% 492
2025
Q4 		$22.6K Buy
+9,284
New +$32.9K ﹤0.01% 485
2022
Q4 		– Sell
-341
Closed -$1K – 402
2022
Q3 		$1K Buy
+341
New +$1.05K ﹤0.01% 383

Other funds holding BDTX

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return

China Universal Asset Management Company's BDTX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Black Diamond Therapeutics (BDTX) stake by 9.8% in Q2 2026, selling an estimated $2.42K and leaving 9,120 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #499.

China Universal Asset Management Company first reported a position in BDTX in Q3 2022 and has held it in 4 quarters since. The position peaked at $22.6K in Q4 2025. 18 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • China Universal Asset Management Company held 9,120 shares of Black Diamond Therapeutics worth $16.9K as of Q2 2026.
  • China Universal Asset Management Company sold 991 Black Diamond Therapeutics shares in Q2 2026, an estimated $2.42K.
  • Black Diamond Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #499 holding.
  • China Universal Asset Management Company first reported a position in Black Diamond Therapeutics in Q3 2022 and has held it in 4 quarters since.
  • China Universal Asset Management Company's Black Diamond Therapeutics position peaked at $22.6K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.